Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3833 | 911 | 41.1 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
204 | 3 | PROTEASOME//UBIQUITIN//UNFOLDED PROTEIN RESPONSE | 52492 |
3833 | 2 | CITED2//BRANCHIO OCULO FACIAL SYNDROME//AP 2 ALPHA | 911 |
19031 | 1 | BRANCHIO OCULO FACIAL SYNDROME//AP 2 ALPHA//AP 2 | 526 |
26432 | 1 | YY1//YIN YANG 1//YY2 | 255 |
33061 | 1 | CITED2//CITED//MELANOCYTE SPECIFIC GENE MSG1 | 130 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CITED2 | authKW | 672945 | 4% | 63% | 32 |
2 | BRANCHIO OCULO FACIAL SYNDROME | authKW | 609397 | 2% | 91% | 20 |
3 | AP 2 ALPHA | authKW | 587223 | 3% | 60% | 29 |
4 | AP 2 | authKW | 571841 | 6% | 29% | 59 |
5 | YY1 | authKW | 502834 | 6% | 27% | 56 |
6 | YIN YANG 1 | authKW | 263013 | 2% | 41% | 19 |
7 | AP 2 EPSILON | authKW | 201102 | 1% | 100% | 6 |
8 | TRANSCRIPTION FACTOR AP 2 | authKW | 193913 | 1% | 64% | 9 |
9 | CHAR SYNDROME | authKW | 182478 | 1% | 78% | 7 |
10 | TFAP2A | authKW | 176396 | 1% | 53% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 2235 | 26% | 0% | 240 |
2 | Developmental Biology | 2169 | 10% | 0% | 92 |
3 | Biochemistry & Molecular Biology | 2100 | 41% | 0% | 375 |
4 | Genetics & Heredity | 1469 | 18% | 0% | 161 |
5 | Oncology | 1077 | 19% | 0% | 176 |
6 | Biophysics | 149 | 6% | 0% | 52 |
7 | Anatomy & Morphology | 51 | 1% | 0% | 11 |
8 | Dermatology | 44 | 2% | 0% | 20 |
9 | Pathology | 37 | 3% | 0% | 23 |
10 | Medicine, Research & Experimental | 34 | 4% | 0% | 32 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CRANIO IAL BIOL CELL DEV BIOL | 69821 | 1% | 42% | 5 |
2 | DEV PATHOL | 49439 | 1% | 13% | 11 |
3 | DIABET NEPHROL | 44688 | 0% | 67% | 2 |
4 | AFFILIATED HOSP 1 ANIM | 33517 | 0% | 100% | 1 |
5 | AFFILIATED HOSP 1 GEN SURG | 33517 | 0% | 100% | 1 |
6 | AFFILICATED HOSP 3 | 33517 | 0% | 100% | 1 |
7 | BIRTH DEFECTS ULSD | 33517 | 0% | 100% | 1 |
8 | CANC BIOL PROGRAMEPITHELIAL PATHOBIOL GRP | 33517 | 0% | 100% | 1 |
9 | CANC EPIGENETSIR RUN RUN SHAW HOSP | 33517 | 0% | 100% | 1 |
10 | CASE TRANSGEN TARGETING IL | 33517 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR AND CELLULAR BIOLOGY | 1903 | 4% | 0% | 36 |
2 | CLINICAL DYSMORPHOLOGY | 1460 | 1% | 1% | 7 |
3 | ONCOGENE | 1414 | 3% | 0% | 28 |
4 | AMERICAN JOURNAL OF PHARMACOGENOMICS | 984 | 0% | 3% | 1 |
5 | DEVELOPMENTAL DYNAMICS | 854 | 1% | 0% | 11 |
6 | DEVELOPMENTAL BIOLOGY | 851 | 2% | 0% | 19 |
7 | JOURNAL OF BIOLOGICAL CHEMISTRY | 792 | 7% | 0% | 63 |
8 | NUCLEIC ACIDS RESEARCH | 767 | 3% | 0% | 31 |
9 | GENOMICS | 663 | 1% | 0% | 13 |
10 | AMERICAN JOURNAL OF MEDICAL GENETICS | 531 | 1% | 0% | 12 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CITED2 | 672945 | 4% | 63% | 32 | Search CITED2 | Search CITED2 |
2 | BRANCHIO OCULO FACIAL SYNDROME | 609397 | 2% | 91% | 20 | Search BRANCHIO+OCULO+FACIAL+SYNDROME | Search BRANCHIO+OCULO+FACIAL+SYNDROME |
3 | AP 2 ALPHA | 587223 | 3% | 60% | 29 | Search AP+2+ALPHA | Search AP+2+ALPHA |
4 | AP 2 | 571841 | 6% | 29% | 59 | Search AP+2 | Search AP+2 |
5 | YY1 | 502834 | 6% | 27% | 56 | Search YY1 | Search YY1 |
6 | YIN YANG 1 | 263013 | 2% | 41% | 19 | Search YIN+YANG+1 | Search YIN+YANG+1 |
7 | AP 2 EPSILON | 201102 | 1% | 100% | 6 | Search AP+2+EPSILON | Search AP+2+EPSILON |
8 | TRANSCRIPTION FACTOR AP 2 | 193913 | 1% | 64% | 9 | Search TRANSCRIPTION+FACTOR+AP+2 | Search TRANSCRIPTION+FACTOR+AP+2 |
9 | CHAR SYNDROME | 182478 | 1% | 78% | 7 | Search CHAR+SYNDROME | Search CHAR+SYNDROME |
10 | TFAP2A | 176396 | 1% | 53% | 10 | Search TFAP2A | Search TFAP2A |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PELLIKAINEN, JM , KOSMA, VM , (2007) ACTIVATOR PROTEIN-2 IN CARCINOGENESIS WITH A SPECIAL REFERENCE TO BREAST CANCER - A MINI REVIEW.INTERNATIONAL JOURNAL OF CANCER. VOL. 120. ISSUE 10. P. 2061-2067 | 79 | 71% | 56 |
2 | ECKERT, D , BUHL, S , WEBER, S , JAGER, R , SCHORLE, H , (2005) THE AP-2 FAMILY OF TRANSCRIPTION FACTORS.GENOME BIOLOGY. VOL. 6. ISSUE 13. P. - | 57 | 74% | 181 |
3 | SHI, JM , HAO, AX , ZHANG, Q , SUI, GC , (2015) THE ROLE OF YY1 IN ONCOGENESIS AND ITS POTENTIAL AS A DRUG TARGET IN CANCER THERAPIES.CURRENT CANCER DRUG TARGETS. VOL. 15. ISSUE 2. P. 145 -157 | 72 | 46% | 4 |
4 | HILGER-EVERSHEIM, K , MOSER, M , SCHORLE, H , BUETTNER, R , (2000) REGULATORY ROLES OF AP-2 TRANSCRIPTION FACTORS IN VERTEBRATE DEVELOPMENT, APOPTOSIS AND CELL-CYCLE CONTROL.GENE. VOL. 260. ISSUE 1-2. P. 1 -12 | 49 | 71% | 219 |
5 | WENKE, AK , BOSSERHOFF, AK , (2010) ROLES OF AP-2 TRANSCRIPTION FACTORS IN THE REGULATION OF CARTILAGE AND SKELETAL DEVELOPMENT.FEBS JOURNAL. VOL. 277. ISSUE 4. P. 894-902 | 49 | 63% | 18 |
6 | LI, H , SHERIDAN, R , WILLIAMS, T , (2013) ANALYSIS OF TFAP2A MUTATIONS IN BRANCHIO-OCULO-FACIAL SYNDROME INDICATES FUNCTIONAL COMPLEXITY WITHIN THE AP-2 DNA-BINDING DOMAIN.HUMAN MOLECULAR GENETICS. VOL. 22. ISSUE 16. P. 3195 -3206 | 38 | 69% | 5 |
7 | FENG, WG , WILLIAMS, T , (2003) CLONING AND CHARACTERIZATION OF THE MOUSE AP-2 EPSILON GENE: A NOVEL FAMILY MEMBER EXPRESSED IN THE DEVELOPING OLFACTORY BULB.MOLECULAR AND CELLULAR NEUROSCIENCE. VOL. 24. ISSUE 2. P. 460-475 | 45 | 71% | 58 |
8 | SU, WJ , XIA, J , CHEN, XQ , XU, M , NIE, L , CHEN, N , GONG, J , LI, XL , ZHOU, Q , (2014) ECTOPIC EXPRESSION OF AP-2 ALPHA TRANSCRIPTION FACTOR SUPPRESSES GLIOMA PROGRESSION.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. VOL. 7. ISSUE 12. P. 8666 -8674 | 33 | 77% | 0 |
9 | TUMMALA, R , ROMANO, RA , FUCHS, E , SINHA, S , (2003) MOLECULAR CLONING AND CHARACTERIZATION OF AP-2 EPSILON, A FIFTH MEMBER OF THE AP-2 FAMILY.GENE. VOL. 321. ISSUE . P. 93-102 | 30 | 97% | 51 |
10 | BONAVIDA, B , KAUFHOLD, S , (2015) PROGNOSTIC SIGNIFICANCE OF YY1 PROTEIN EXPRESSION AND MRNA LEVELS BY BIOINFORMATICS ANALYSIS IN HUMAN CANCERS: A THERAPEUTIC TARGET.PHARMACOLOGY & THERAPEUTICS. VOL. 150. ISSUE . P. 149 -168 | 52 | 40% | 2 |
Classes with closest relation at Level 2 |